Crossmark

Microphysiological lung models to evaluate the safety of new pharmaceutical modalities: a biopharmaceutical perspective

Crossref DOI link: https://doi.org/10.1039/C9LC00492K

Published Online: 2019

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Ainslie, Garrett R. https://orcid.org/0000-0002-6805-2873
Davis, Myrtle

Ewart, Lorna

Lieberman, Linda A.

Rowlands, David J.

Thorley, Andrew J. https://orcid.org/0000-0001-7854-7012
Yoder, Gorm

Ryan, Anne M.
License Information

Accepted Manuscript valid from 2020-08-30
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

IDENTIFIERS

: Garrett R. Ainslie (ORCID)

: Andrew J. Thorley (ORCID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 24 May 2019; Accepted 27 July 2019; Advance Article published 30 August 2019; Version of Record published 27 September 2019